NEOS Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.13M Buy
23,734
+2,894
+14% +$554K 0.02% 359
2026
Q1
$3.82M Buy
20,840
+4,306
+26% +$793K 0.02% 382
2025
Q4
$2.91M Sell
16,534
-40,767
-71% -$6.66M 0.02% 420
2025
Q3
$8.03M Buy
57,301
+20,490
+56% +$2.77M 0.06% 231
2025
Q2
$4.62M Buy
36,811
+14,113
+62% +$1.76M 0.06% 253
2025
Q1
$3.11M Buy
22,698
+5,074
+29% +$725K 0.06% 265
2024
Q4
$2.7M Buy
17,624
+2,740
+18% +$462K 0.06% 250
2024
Q3
$2.89M Buy
14,884
+1,893
+15% +$396K 0.09% 208
2024
Q2
$3.01M Buy
12,991
+3,243
+33% +$705K 0.12% 150
2024
Q1
$2.1M Buy
9,748
+2,911
+43% +$682K 0.13% 149
2023
Q4
$1.77M Buy
6,837
+353
+5% +$86.7K 0.17% 120
2023
Q3
$1.67M Buy
+6,484
New +$1.73M 0.21% 99

Other funds holding BIIB

NEOS Investment Management's BIIB Position: Q2 2026 in Review

NEOS Investment Management increased its Biogen (BIIB) stake by 14% in Q2 2026, buying an estimated $554K and bringing the position to 23,734 shares worth $5.13M. The position accounts for 0.02% of the portfolio, ranked #359.

NEOS Investment Management first reported a position in BIIB in Q3 2023 and has held it in 12 quarters since. The position peaked at $8.03M in Q3 2025. 1,044 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • NEOS Investment Management held 23,734 shares of Biogen worth $5.13M as of Q2 2026.
  • NEOS Investment Management bought 2,894 Biogen shares in Q2 2026, an estimated $554K.
  • Biogen made up 0.02% of NEOS Investment Management's portfolio in Q2 2026, its #359 holding.
  • NEOS Investment Management first reported a position in Biogen in Q3 2023 and has held it in 12 quarters since.
  • NEOS Investment Management's Biogen position peaked at $8.03M in Q3 2025.
  • 1,044 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on NEOS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.